[The mechanism and current strategies for preventing the recurrence of hepatocellular carcinoma after liver transplantation].

Wang, H Q; Li, L; Yang, J Y

Wang, H Q; Li, L; Yang, J Y.

Affiliation

Wang HQ; Department of Hepato-Biliary-Pancreatic Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, China.
Li L; Department of Organ Transplantation Center, West China Hospital of Sichuan University, Chengdu 610041, China.
Yang JY; Department of Organ Transplantation Center, West China Hospital of Sichuan University, Chengdu 610041, China.

Zhonghua Gan Zang Bing Za Zhi ; 26(2): 93-97, 2018 Feb 20.

Article in Zh | MEDLINE | ID: mdl-29804373

Subject(s)

Carcinoma, Hepatocellular/surgery; Liver Neoplasms/surgery; Liver Transplantation/methods; Neoplasm Recurrence, Local/prevention & control; Adult; Carcinoma, Hepatocellular/pathology; Hepatectomy; Humans; Liver Neoplasms/pathology; Liver Transplantation/adverse effects; Neoplasm Recurrence, Local/drug therapy; Retrospective Studies; Risk Factors; TOR Serine-Threonine Kinases

Key words

Carcinoma, hepatocellular; Immunosuppressant; Liver transplantation; Recurrence

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Transplantation / Carcinoma, Hepatocellular / Liver Neoplasms / Neoplasm Recurrence, Local Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: Zh Journal: Zhonghua Gan Zang Bing Za Zhi Journal subject: GASTROENTEROLOGIA Year: 2018 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google